Velar Capital

Lineaje specializes in addressing critical security challenges in the Software Supply Chain faced by organizations involved in software development, usage, or distribution. The company offers a comprehensive platform that ensures software integrity throughout its lifecycle, from creation to deployment.

Macrometa Corporation is an information technology company that specializes in developing a geo-distributed data as a service platform for cross-region, multi-cloud, and edge computing applications. Founded in 2017 and headquartered in San Mateo, California, with operations in Sofia, Bulgaria, and Pune, India, Macrometa provides a platform that allows enterprise developers to build real-time applications and APIs rapidly. Its offerings include a global data mesh, a multi-model data store, and a complex event processing engine, supported by over 175 edge data centers worldwide. The company's serverless cloud architecture enables cloud developers to manage, process, and serve data and APIs from the edge, enhancing the performance of data-driven applications.

Molecula Research Laboratories, LLC is a company that specializes in providing antisense oligonucleotides for researchers, focusing on protein function studies and gene expression solutions through proprietary RNAi technology. Founded in 1993 and based in Herndon, Virginia, Molecula also offers a range of products including neuropeptides under the brand name Princeton Peptides, as well as transfection reagents such as Maxfect and Genfect. Additionally, the company has developed a novel IPTG replacement, known as the Inducer, to enhance soluble protein production. Alongside its research offerings, Molecula develops data virtualization software that enables secure access to large and fragmented datasets. This software supports AI applications by facilitating efficient processing of massive datasets, allowing organizations to leverage real-time information for better decision-making.

FeatureBase, operating as Molecula Research Laboratories, LLC, specializes in providing advanced solutions for researchers, particularly in the fields of protein function studies and gene expression. The company utilizes proprietary RNA interference technology to deliver antisense oligonucleotides and offers a range of products, including neuropeptides marketed under the brand Princeton Peptides, as well as transfection reagents such as Maxfect and Genfect. Additionally, Molecula has developed the Inducer, an innovative substitute for IPTG that enhances soluble protein production. With its Cloud Data Access platform, Molecula simplifies and accelerates access to big data, enabling users to create highly efficient data representations without the need for pre-aggregation or data movement. Founded in 1993 and based in Herndon, Virginia, the company continues to advance research capabilities in the life sciences.